Patents by Inventor Nelly Frossard

Nelly Frossard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokines
    Patent number: 11046657
    Abstract: A subject of the present invention is a compound having the general formula (I): a pharmaceutically acceptable salt thereof or a tautomeric form thereof, wherein A, B3, B4, B5, Y, X, B1 and B2 are as defined in any one of claims 1 to 10. Another subject of the invention is the compound as defined above for use as a medicament, in particular for preventing and/or treating inflammation and inflammatory diseases, immune and auto-immune diseases, pain related diseases, genetic diseases and/or cancer.
    Type: Grant
    Filed: July 13, 2017
    Date of Patent: June 29, 2021
    Assignees: Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, Universite de Strasbourg, Universite Paris-Sud, Centre International de Recherche aux Frontieres de la Chimie
    Inventors: Dominique Bonnet, Nelly Frossard, Jean-Luc Galzi, Christophe Guignabert, Marcel Hibert, Frédéric Simonin, Sylviane Muller
  • Dermocosmetic or pharmaceutical use of a composition comprising at least one inhibitor of some chemoattractant cytokines
    Patent number: 10828309
    Abstract: The present invention relates to the cosmetic or pharmaceutical use for a composition comprising a salicylic or nicotinic acid derivative inhibiting chemokines, for preventing or treating chronic internal and/or external inflammatory conditions.
    Type: Grant
    Filed: September 22, 2015
    Date of Patent: November 10, 2020
    Assignees: GREENPHARMA, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE DE STRASBOURG
    Inventors: Philippe Bernard, Dayana Abboud, Jean-Luc Galzi, Nelly Frossard, Christelle Pillard, Quoc Tuan Do
  • Pyrimidinone Derivatives and Uses Thereof to Neutralize the Biological Activity of Chemokines
    Publication number: 20200181093
    Abstract: A subject of the present invention is a compound having the general formula (I): a pharmaceutically acceptable salt thereof or a tautomeric form thereof, wherein A, B3, B4, B5, Y, X, B1 and B2 are as defined in any one of claims 1 to 10. Another subject of the invention is the compound as defined above for use as a medicament, in particular for preventing and/or treating inflammation and inflammatory diseases, immune and auto-immune diseases, pain related diseases, genetic diseases and/or cancer.
    Type: Application
    Filed: July 13, 2017
    Publication date: June 11, 2020
    Applicants: Centre National de la Recherche Scientifique (CNRS, Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Strasbourg, Universite Paris-Sud, Centre International de Recherche aux Frontieres d e la Chimie
    Inventors: Dominique Bonnet, Nelly Frossard, Jean-Luc Galzi, Christophe Guignabert, Marcel Hibert, Frédéric Simonin, Sylviane Muller
  • DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION COMPRISING AT LEAST ONE INHIBITOR OF SOME CHEMOATTRACTANT CYTOKINES
    Publication number: 20170296547
    Abstract: The present invention relates to the cosmetic or pharmaceutical use for a composition comprising a salicylic or nicotinic acid derivative inhibiting chemokines, for preventing or treating chronic internal and/or external inflammatory conditions.
    Type: Application
    Filed: September 22, 2015
    Publication date: October 19, 2017
    Inventors: Philippe BERNARD, Dayana ABBOUD, Jean-Luc GALZI, Nelly FROSSARD, Christelle PILLARD, Quoc Tuan DO
  • DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES
    Publication number: 20170281653
    Abstract: The present invention relates to the cosmetic or pharmaceutical use for a composition comprising a salicylic or nicotinic acid derivative inhibiting chemokines, for preventing or treating chronic internal and/or external inflammatory conditions.
    Type: Application
    Filed: September 22, 2015
    Publication date: October 5, 2017
    Inventors: Philippe BERNARD, Dayana ABBOUD, Jean-Luc GALZI, Nelly FROSSARD, Christelle PILLARD, Quoc Tuan DO
  • BIOMARKER FOR CHRONIC INFLAMMATORY LUNG DISEASES
    Publication number: 20140371099
    Abstract: The invention relates to an in vitro method for the diagnosis and/or prognosis and/or evaluation of the progression of a chronic inflammatory lung disease in a subject, using the level of expression of the GPR15 G protein-coupled receptor gene as a biomarker for the disease.
    Type: Application
    Filed: January 31, 2013
    Publication date: December 18, 2014
    Inventors: Nelly Frossard, Jacques Haiech, Christine Lehalle, Romain Kessler, Antoine Magnan, Pascal Chanez, Jean-Luc Galzi